HighVista Strategies’s Adamas Pharmaceuticals ADMS Stock Holding History

HighVista Strategies’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-21,193	Closed	-$104K	–	140
2021 Q3	$104K	Buy	21,193 +6,437	+44%	+$31.3K	0.07%	95
2021 Q2	$78K	Hold	14,756	–	–	0.06%	106
2021 Q1	$70K	Buy	+14,756	New	+$77.1K	0.05%	116

HighVista Strategies's ADMS Position: Q4 2021 in Review

HighVista Strategies sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 21,193 shares — an estimated $104K sold.

HighVista Strategies first reported a position in ADMS in Q1 2021 and held it in 3 quarters. The position peaked at $104K in Q3 2021. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.

HighVista Strategies reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
HighVista Strategies sold 21,193 Adamas Pharmaceuticals shares in Q4 2021, an estimated $104K.
HighVista Strategies first reported a position in Adamas Pharmaceuticals in Q1 2021 and held it in 3 quarters.
HighVista Strategies's Adamas Pharmaceuticals position peaked at $104K in Q3 2021.
0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.